Clinical Trial

Texting for Diabetes

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Diabetes is a common complication of pregnancy that increases risks for both the mother and baby. Poorly controlled diabetes has been associated with very large babies, congenital heart defects, stillbirth, birth trauma, and maternal infections among other complications. Patients with diabetes in pregnancy require more frequent prenatal visits and fetal evaluation, and must shoulder the burden of mastering management of a complicated care regimen. With the ever-expanding world of technology, more healthcare practices are using cell phones, texting, and social media to interact with patients. Use of this technology has been successful in management of chronic diseases and as reminder systems. The investigators propose a randomized clinical trial to investigate patient adherence to recommended care regimen after intervention of a text message reminder and education system.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2017-01-17; most recent amendment 2025-12-05.
Status change: Recruiting → Active, Not Recruiting 2022-11-11
Status change: Suspended → Recruiting 2020-01-30
Status change: Recruiting → Suspended 2017-11-01
Trial Details
NCT Number NCT03025984
Lead Sponsor St. Louis University
Conditions Diabetes Mellitus
Enrollment 185 participants
Start Date 2016-12
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-15